DTX-501

N/A

Report date: 2024/09/10 14:51:28

Base Information

Drug NameDTX-501
Drug Alias NameDTX-501
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsPhenylketonurias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDimension TherapeuticsUltragenyx Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesDimension TherapeuticsUltragenyx Pharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsPhenylketonurias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A